scholarly journals A case of occult colon cancer with sepsis as the primary manifestation guided by bone marrow puncture

Author(s):  
hua jun wang ◽  
chenjie ZHOU ◽  
jianhua Wang

Abstract Background: Bone marrow metastasis is common in liver cancer and lung cancer, but there are few reports on bone marrow metastasis of colon cancer. So far, there are no research reports from mainland China; especially reports of bone marrow metastasis combined with septic shock as the main manifestation are even rarer. Case presentation: A 71-year-old elderly woman with sepsis as the first symptom, mainly manifested as high fever, low blood pressure, high inflammation indicators, etc. CT examination revealed mild inflammation of the lungs and no obvious abnormalities in the abdomen. Blood culture culture suggested Escherichia coli and Aeromonas hydrophila/caviae. After anti-infective treatment, the patient's sepsis symptoms improved significantly, but after repeated platelet transfusion, he still could not correct hypothrombosis. Finally, a large number of malignant cells were found through a bone marrow puncture smear, and further PET-CT examination confirmed that the ascending colon malignant tumor was accompanied by multiple metastases such as the liver and bones. The patient was eventually unable to tolerate surgery due to bone marrow failure and liver failure and died 3 weeks after admission.Conclusions: We hope that this case report can raise people’s awareness of the insidiousness of colon cancer and the possibility of metastasis to the bone marrow, especially for patients with progressive thrombocytopenia that is difficult to correct. Thrombocytopenia needs to be treated differently from sepsis.

2014 ◽  
Vol 8 (6) ◽  
pp. 2672-2674 ◽  
Author(s):  
DO HYOUNG LIM ◽  
SOON IL LEE ◽  
KEON WOO PARK

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 11012-11012 ◽  
Author(s):  
Elba Etchebehere ◽  
John C. Araujo ◽  
Denai Milton ◽  
Patricia S Fox ◽  
Nancy Swanston ◽  
...  

2012 ◽  
Vol 66 (6) ◽  
pp. 448-453 ◽  
Author(s):  
Laura Evangelista ◽  
Annalori Panunzio ◽  
Roberta Polverosi ◽  
Alice Ferretti ◽  
Sotirios Chondrogiannis ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Cheng Huang ◽  
Binglin Jian ◽  
Yan Su ◽  
Na Xu ◽  
Tong Yu ◽  
...  

Abstract Background The aim of this study was to summarize the clinical characteristics, therapeutic effects and prognosis of patients with rhabdomyosarcoma (RMS) and bone marrow metastasis, improve the understanding of this disease. Method This was a single-institution retrospective study involving the children with RMS, who presented with bone marrow metastasis at initial presentation to our hospital between 1st, Jan, 2006 and 31st, Dec,2019. Follow-up concluded on 31st, Dec, 2020 and the clinical data were collected and analysed. Result Between 1st Jan 2006 and 31st Dec 2019, 13 eligible patients presented to our hospital, including 10 males and 3 females, these eligible patients accounted for 4.5% of all RMS patients. The median age at onset was 5.6 years (range 1.7-14 years). The patients not only had unfavourable primary sites, but also had multiple metastases. The bone marrow aspirate samples of the patients comprised 8-95% blast-like cells. Nine of 13 patients were misdiagnosed with haematological malignancies or other solid tumours. With respect to histology, four of 13 children were classified as embryonal RMS and nine as alveolar RMS. Eleven patients underwent PAX-FOXO1 fusion testing; eight had the POX- FOXO1 fusion gene. Immunohistochemically(IHC) analysis revealed that the tumour cells were positive for Desmin, Vimentin, Myo-D1 and Myogenin. More importantly, the patients had extremely poor prognoses, the median EFS was 12.0 months (range 3-28.3 months) and the median OS was 27.0 months (range6-46.2 months). Conclusion This study demonstrates that children with RMS and bone marrow metastasis usually exhibit atypical primary sites and multiple metastases, with presentation mimicking haematological malignancies or other solid tumors at initial presentation. Pathology and IHC analysis combined with POX-FOXO1 fusion gene detections can effectively confirm the diagnosis. These patients are more likely to relapse or progress during early treatment and are prone to intracranial metastasis. While multidisciplinary therapy combined with Temozolomide may prevent it, further prospective research is required to evaluate the therapeutic effects.


2020 ◽  
Vol 45 (1) ◽  
pp. e20-e23
Author(s):  
Hiroaki Takahashi ◽  
Tadashi Hara ◽  
Hideo Suzuki ◽  
Ryosuke Hashimoto ◽  
Manabu Minami

2016 ◽  
Vol 41 (4) ◽  
pp. 268-273 ◽  
Author(s):  
Elba C. Etchebehere ◽  
John C. Araujo ◽  
Denái R. Milton ◽  
William D. Erwin ◽  
Richard E. Wendt ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Medhat M. Osman ◽  
Amir Iravani ◽  
Michael S. Hofman ◽  
Rodney J. Hicks

Abstract Background Recent studies reported metabolic uptake in at least one of the evaluated ganglia in 98.5% of patients undergoing 68Ga -PSMA-11 and in 96.9% of patients undergoing 18F-DCFPyL PET/CT examination. We have observed different patterns of ganglion visualization with 18F-DCFPyL compared to 68Ga-PSMA-11. This includes more frequent visualization of cervical and sacral ganglia, which may be attributable to better imaging characteristics with 18F PET imaging. Case presentation This pictorial essay is to illustrate and compare, in the same patient, various representative cases of 68Ga-PSMA-11 and 18F-DCFPyL PET/CT uptake in ganglia at different anatomic locations, with different patterns and distribution of metabolic activity. Conclusion Reading physicians should be aware of the frequently encountered and occasionally different physiologic uptake of 68Ga-PSMA-11 and 18F DCFPyL in different ganglia.


2010 ◽  
Vol 49 (02) ◽  
pp. N10-N12 ◽  
Author(s):  
F. Cicone ◽  
M. Stalder ◽  
D. Geiger ◽  
A. Cairoli ◽  
A. Bischof Delaloye ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document